News & Analysis on Clinical Trial Services & Contract Research And Development
Expansion has been a theme for German pharmaceutical packaging firms of late with the acquisition of Seidenader Maschinenbau by the Kober Group following just weeks after Edelmann bought a stake in Hungary’s Zalai Nyomda
siRNA-focused CRO Cenix BioScience has set up an R&D subsidiary in Belgium, citing growing demand for this type of specialised contracting.
KV Pharmaceutical saw its share price plummet after an FDA delay prompted it to evaluate its liquidity outlook.
Telstar Group and Puretech Process Systems are teaming up to meet the flood of pharma and biotech demand for water treatment technologies.
Merck plans to cash in on the biogenerics industry after forming a partnership with Parexel to develop copies of biologic drugs within its Merck BioVentures division.
Codexis will supply DSM Pharmaceutical Products with custom biocatalysis services and enzymes under a contract signed this week.
Genzyme has lowered 2011 financial projections after delaying the date it expects Fabrazyme production to return to normal.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at inVentiv, AMRI, ShangPharma and ERT.